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EFFECT OF CYTOSTATIC AGENTS ON EXPRESSION LEVELS 
OF HUMAN BETA-DEFENSINS-1-4  
IN A431 AND MCF-7 CELL LINES
O.S. Zubenko*, D.O. Semeniuk, I.O. Starenka, P.V. Pogribnyy
R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, NAS of Ukraine,  
Kyiv 03022, Ukraine
The aim of the study was to analyze an effect of cytostatic agents of different mechanism of action on expression levels of human 
beta-defensins-1-4 (hBD-1-4) in cultured human cancer cell lines. Materials and Methods: Expression levels of hBD-1-4 mRNA 
were assessed using qPCR in human epidermoid carcinoma A431 cells and human breast adenocarcinoma MCF7 cells treated with 
cisplatin, methotrexate, doxorubicin or vincristine at the IC20 concentrations. Results: The cytostatic agents with different mecha-
nisms of action affected differently expression of hBDs, dependent on the cell line. Mostly, cytostatic agents suppressed significantly 
expression of hBDs. In contrast, vincristine caused significant up-regulation of hBD-1 (12 fold, p < 0.05) and hBD-4 (2 fold, 
p < 0.05) in MCF7, and doxorubicin significantly enhanced expression of hBD-3 (2 fold, p < 0.05) and hBD-4 (> 10 fold, p < 0.05) 
in A431 cells. Conclusion: The results of this pilot study show that expression levels of hBD-1-4 may be altered upon treatment with 
cytostatic agents depending on nature of cells.
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Human defensins are cationic cysteine-ric� anti-
microbial peptides and represent important compo-
nents of innate immune system. Depending on t�eir 
structure� in particular� disulfide bonding� defensins 
are classified into t�e subfamilies of alp�a- and 
beta-defensins ��uman beta-defensins — �BDs�. 
Originally defensins were described as antibacte-
rial peptides� but furt�er researc� s�owed t�at t�ey 
�ave a wide range of functions in t�e �uman body. 
As t�e molecules capable to link innate and adap-
tive immunity� defensins are ascribed to t�e family 
of alarmins� molecules involved in danger signaling; 
it is supposed t�at t�ey may play a role in t�e tumor 
microenvironment [�]. Apart from t�is� some defen-
sins are capable to cause tumor cell lysis and exert 
pro- or antitumorigenic and angiogenic activities [�]. 
Hypot�etically� beta-defensins could be capable 
to influence t�e cancer cell sensitivity to cytototoxic 
agents. To address t�is issue� we �ave analyzed t�e 
influence of cytostatic agents of different mec�a-
nisms of action on t�e expression of beta-defensins 
in cultured �uman cancer cell lines.
MATERIALS AND METHODS
Cell lines. In t�e experiment� we used �uman 
epidermoid carcinoma A�3� and �uman breast ad-
enocarcinoma �CF� cell lines. T�e cell lines were 
obtained from t�e Bank of Cell Lines from Human and 
Animal Tissues of t�e R.E. Kavetsky Institute of Ex-
perimental Pat�ology� Oncology and Radiobiology� 
NAS of Ukraine. A�3� and �CF� cells were cultured 
in D�E� medium supplemented wit� ��% fetal bo-
vine serum �FBS�� in a �umidified atmosp�ere wit� 
5% CO� at 3� °C.
Analysis of cell  viability (MT T-assay). 
To evaluate t�e effect of cytotoxic agents on cell 
viability� �TT met�od was used [3]. In s�ort� tumor 
cells were seeded in 96-well plates (7•103 cells 
per well� and incubated wit� cytotoxic agents 
�doxorubicin� cisplatin� vincristine� met�otrexate 
in a wide range of concentrations ��.���5 mg/ml; 
�.�5�5� mg/ml; �.��5�5 mg/ml; �.5�5�� mg/ml� 
respectively� in D�E� medium� wit� t�e addition 
of �.5% FBS for �� �. T�en t�e cells were treated 
wit� 3-���5-dimet�ylt�iazol-�-yl�-��5-dip�enyl-
tetrazolium ��TT� reagent by standard protocol. 
Colorimetric reaction was evaluated using a Plate 
Analyzer StarFax ���� at a wavelengt� of ��� nm.
Isolation of total RNA. Isolation of total RNA 
from cultured cells was carried out using t�e Trizol 
reagent. T�e concentration of RNA was determined 
by spectrop�oto metry at a wavelengt� of �6� nm us-
ing a NanoDrop ���� mac�ine. T�e quality of RNA 
was assessed by electrop�oresis in �% agarose gels.
Quantitative real-time PCR.  Expression 
of beta-defensins in A�3� and �CF� cells treated 
wit� cytotoxic agents was analyzed by quantitative 
polymerase c�ain reaction �qPCR� using specific 
primers. Design of primers was performed using 
Oligo 6.3� program.
T�e reaction was carried out in a volume of �� ml� 
containing �� ml mixture of reagents �axima SYBR 
Green/ROX qPCR �aster �ix� �.5 pmol of eac� 
specific primer� � ml of cDNA obtained in t�e reverse 
transcription reaction and demineralized water. T�e 
reaction was performed on T�ermocycler �5�� Real-
Time PCR System. T�e reaction conditions and se-
quences of specific primers are s�own in t�e Table �.
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Abbreviations used: СP — cisplatin; DOX — doxorubicin; FBS — fe-
tal bovine serum; hBD — human beta-defensin; МЕТ — methotrex-
ate; MTT — 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium; 
qPCR — quantitative polymerase chain reaction; VIN — vincristine.
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Table 1. Conditions for quantitative real time PCR
Gene Primer Conditions
Beta-actin F: GAAATCGTGCGTGACATTAA
R: CCAGACAGCACTGTGTTGG
Denaturation — 94 °С, 15 s
Annealing/Elongation — 
59 °С, 60 s
Number of cycles — 40
HBD-1 F: CTCCCCAGTTCCTGAAATCCT
R: GCCTGTGAGAAAGTTACCACC
Denaturation — 94 °С, 15 s
Annealing — 57 °С, 30 s
Elongation — 72 °С, 30 s
Number of cycles — 40
HBD-2 F: TGAAGCTCCCAGCCATCAG
R: ATCGCCTATACCACCAAAAACAC
Denaturation — 94 °С, 15 s
Annealing — 57 °С, 30 s
Elongation — 72 °С, 30 s
Number of cycles — 40
HBD-3 R: CCTGTTTTTGGTGCCTGTTCC
R: CTTTCTTCGGCAGCATTTTCG
Denaturation — 94 °С, 15 s
Annealing — 57 °С, 30 s
Elongation — 72 °С, 30 s
Number of cycles — 40
HBD-4 F: GACTTGTGCTGCTATTAGCCA
R: CGATTCAGTAAGCTCTCATCC
Denaturation — 94 °С, 15 s
Annealing — 57 °С, 30 s
Elongation — 72 °С, 30 s
Number of cycles — 40
T�e t�res�old fluorescence level was determined 
using software SDS software V.�.3.�. Gene expres-
sion was normalized by t�e reference gene �beta-ac-
tin�� comparison of gene expression was performed 
by �-δδCt met�od.
Statistical analysis. To determine t�e signifi-
cance of t�e differences between t�e data groups 
Student’s t-criterion was used. T�e differences 
were considered significant at p < �.�� for �TT 
test and p < �.�5 for qPCR. T�e data are presented 
as � ± m.
RESULTS AND DISCUSSION
In present researc�� we aimed to analyze t�e ef-
fect of cytostatic agents commonly used in clinical 
practice� i.e. cisplatin� doxorubicin� vincristine� and 
met�otrexate on expression of �BDs mRNAs in two 
cancer cell lines� A�3� and �CF�. T�ese cytostatic 
agents are known to cause cytotoxic effects via differ-
ent mec�anisms: �� cisplatin� inorganic water-soluble 
platinum complex� acts as DNA crosslinker� disturbing 
replication and translation; �� doxorubicin� ant�ra-
cycline antibiotic� intercalates DNA and blocks its 
replication; 3� met�otrexate� folate analog� is an an-
timetabolite blocking t�e synt�esis of t�ymidine� 
purine and pyrimidine; and �� vincristine is an alkaloid 
capable to bind wit� microtubules and prevents t�e 
formation of mitotic spindles� consequently blocking 
cell mitosis. To study effects of t�ese agents on �BDs 
expression in vitro� first of all� we �ave determined 
minimal concentrations of t�e cytotoxic drugs caus-
ing a significant decrease of tumor cell viability using 
�TT assay. T�ese concentrations corresponding 
to IC�� values �Table �� were used in our furt�er 
experiments. Breast cancer cells were muc� more 
sensitive to t�e studied cytostatics t�an epidermoid 
carcinoma cells.
Table 2. ІС20 values for cytostatic agents estimated in culture 
of А431 and MCF7 cells
ІС20 agent А431, µg/ml MCF7, µg/ml
Doxorubicin 42 ± 3 0.19 ± 0.02
Cisplatin 4.4 ± 1.5 0.13 ± 0.02
Methotrexate 60 ± 9 1.8 ± 0.2
Vincristine 0.4 ± 0.2 0.16 ± 0.02
Expression of �BD-�-� mRNAs in t�e A�3� and 
�CF� cell line treated wit� minimal effective con-
centrations of cytotoxic agents was assessed wit� 
qPCR �Fig. ��  ��. As it �as been s�own� expression 
of �BD-� gene significantly decreased after incuba-
tion of bot� cell lines wit� cisplatin� met�otrexate and 
doxorubicin� especially in A�3� cells �by �� ± �� times 
in cisplatin-treated A�3� cells� and 6� ± 6 times 
in met�otrexate-treated А�3�� p < �.�5� �Fig. �� �� a�. 
In contrary� treatment wit� vincristine did not cause 
significant influence on t�e expression of �BD-� gene 
in A�3� cells� but significantly stimulate its expression 
in �CF� cells �up to �� ± �.� fold� p < �.�5� �Fig. �� a�. 
Expression of �BD-� gene drastically fall in A�3� cells 
treated wit� any of mentioned agents: by �� ± 5 fold� 
��� ± 3� fold� ��� fold� and �5� ± 3� fold in t�e cells 
treated wit� doxorubicin� met�o trexate� cisplatin� and 
vincristine� respectively �p < �.�5� �Fig. �� b�. Interest-
ingly� in �CF� cells t�e cytostatic agents �ad no effect 
of t�e level of �BD-� expression as well as expression 
of �BD-3 gene. Interestingly� in A�3� cells expression 
of �BD-3 gene increased more t�an � fold and expres-
sion of �BD-� more t�an �� fold after treatment wit� 
doxorubicin �p < �.�5�. Regarding �BD-3 and �BD-� ex-
pression in �CF� cells treated wit� cytostatic agents� 
significant differences were detected just in � cases: 
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Fig. 1. Effect of cytotoxic agents on t�e expression of �BD� �a�� 
�BD-� �b�� �BD-3 �c� and �BD-� �d� in A�3� cell line. C — control 
sample; �ET — 6� mg/ml met�otrexate; DOX — �� mg/ml doxo-
rubicin; CP — �.� mg/ml cisplatin; VIN — �.� mg/ml vincristin 
sulfate. T�e data are presented as � ± m� n = �.
*T�e difference is significant compared wit� t�e control� p < �.�5
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expression of �BD-� genes was significantly down-
regulated by МЕТ �by �3 ± � fold� p < �.�5� and sig-
nificantly up-regulated by vincristine �by �.� ± �.� fold� 
p < �.�5� �Fig. �� d�.
T�e obtained data �ave s�own t�at t�e cytostatic 
agents wit� different mec�anisms of action differen-
tially affect expression of �BDs dependent on cell line. 
�ostly� cytostatic agents suppress expression of �BDs� 
�owever vincristine caused significant up-regulation 
of �BD-� and �BD-� genes in breast cancer cells� 
w�ile doxorubicin significantly en�anced expression 
of �BD-3 and �BD-� genes in A�3� cells. It is tempt-
ing to speculate t�at t�e mentioned above effects 
of particular �BDs up-regulation caused by vincristine 
in �CF-� cells and doxorubicin in A�3� cells could point 
on possible protective functions of t�ese defensins 
in t�e cells undergoing cytotoxic treatment.
Unfortunately� t�e studies in t�is field are scarce. 
For example� it was reported t�at doxorubicin in�i-
bits t�e expression of �BD-3 in orop�aryngeal cancer 
cells� possibly� via activation of t�e transcription factor 
p53� w�ic� is a repressor of �BD-3 gene transcrip-
tion [�]. Anot�er study reported t�at met�otrexate 
is capable to block induction of �BD-� expression 
in �FOB cells [5]. An interesting observation �as been 
done regarding alp�a-defensins expression in breast 
tumors. In t�is researc�� proteomic and genetic profiling 
of pretreatment breast cancer biopsies demonstrated 
t�at expression of alp�a-defensins and a microtubule-
associated protein �AP� is associated wit� pat�ologic 
complete response to t�erapy wit� taxanes� antimicro-
tubule agents� in t�e patients wit� breast cancer [6]. So� 
alp�a-defensins could be considered as t�e markers 
of sensitivity of breast tumors to taxane-based t�erapy.
In conclusion� our pilot study �as revealed t�at cyto-
static agents wit� different mec�anism of action differen-
tially affect expression of beta-defensins-�-� in two cul-
tured tumor cell lines. Expression of �BD-� gene was t�e 
most sensititve for cytotoxic treatments and significantly 
decreased in t�e presence of any of t�em in A�3� cells. 
Expression of �BD-� gene was t�e most protected against 
cytotoxic influence� moreover� it significantly increased un-
der t�e action of doxorubicin in A�3� cells and vincristine 
in �CF� cells. Furt�er study will possibly �elp to under-
stand w�et�er beta-defensins� especially� �BD-� could 
play a role in t�e protection of cancer cells against cyto-
toxic agents or in t�eir sensibilization to cytostatic drugs.
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Fig. 2. Effect of cytotoxic agents on t�e expression of �BD� �a�� 
�BD-� �b�� �BD-3 �c� and �BD-� �d� in �CF� cell line. C — control 
sample; �ET — �.� mg/ml met�otrexate; DOX — �.�� mg/ml doxo-
rubicin; CP — �.�3 mg/ml cisplatin; VIN — �.�6 mg/ml vincristin 
sulfate. T�e data are presented as � ± m� n = �.
*T�e difference is significant compared wit� t�e control� p < �.�5
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